Plethico Pharmaceuticals acquires US-based Natrol Inc for 80.7 million dollars  consolidating its position as a global player in herbal healthcare products.

Plethico Pharmaceuticals acquires US-based Natrol Inc for 80.7 million dollars (Rs 317.07 crore) to consolidate its position as a global player in herbal healthcare products.

The acquisition would be made by an initial tender offer to acquire the outstanding stock of the US-based manufacturer of nutritional products Natrol Inc at USD 4.40 per share. Around 42.3 per cent of Natrol stockholders have committed to tender their shares in the offer, the company said.

The tender offer would commence on November 27 and would remain open for a minimum 20 business days, subject to extension under certain circumstances.